Edmond DE Rothschild Holding S.A. Makes New Investment in Cigna Group $CI

Edmond DE Rothschild Holding S.A. bought a new stake in shares of Cigna Group (NYSE:CI) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,888 shares of the health services provider’s stock, valued at approximately $520,000.

Several other hedge funds also recently modified their holdings of the business. Uptick Partners LLC acquired a new position in Cigna Group in the second quarter valued at approximately $253,000. AssuredPartners Investment Advisors LLC acquired a new stake in Cigna Group during the 2nd quarter worth $305,000. Johnson Financial Group Inc. acquired a new stake in Cigna Group during the 2nd quarter worth $29,000. Tocqueville Asset Management L.P. bought a new stake in shares of Cigna Group during the 2nd quarter valued at $1,307,000. Finally, Addison Advisors LLC bought a new stake in shares of Cigna Group during the 2nd quarter valued at $129,000. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider owned 27,256 shares in the company, valued at $7,530,015.12. The trade was a 41.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 23,012 shares of company stock worth $6,386,550 in the last quarter. 0.60% of the stock is currently owned by company insiders.

Cigna Group Price Performance

Shares of CI stock opened at $274.50 on Friday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The firm has a fifty day moving average of $284.63 and a 200-day moving average of $281.41. The firm has a market capitalization of $72.53 billion, a price-to-earnings ratio of 11.36, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm’s revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities research analysts forecast that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CI. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Wolfe Research reissued an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a research note on Tuesday, June 16th. Piper Sandler reduced their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Robert W. Baird set a $362.00 target price on Cigna Group in a research report on Friday, July 31st. Finally, Barclays upped their price target on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.